Jayastu Senapati, Leukemia fellow at MD Anderson Cancer Centre, shared on X/Twitter:
“Check out the commentary to our paper in the Blood Journal by Paresh Vyas: Changing treatment changing prognosis of mutations. Our manuscript is now out in full: Venetoclax and its effects in AML with Splicing factor gene mutation.”
Source: Jayastu Senapati/Twitter